Ebola Persistence Documented in Monkeys

In tissue samples from rhesus macaques, researchers find the virus in the same immune-privileged sites where Ebola has been found to persist in humans.

Written byAshley P. Taylor
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Ebola virus (red) in the eye of a rhesus monkey survivor COURTESY OF XIANKUN (KEVIN) ZENGAlthough the Ebola outbreak in West Africa that started in 2013 was declared over more than a year ago, the disease lingers on. Many Ebola survivors have suffered from joint aches, vision problems, hearing loss, headaches, and other symptoms, a phenomenon dubbed “post-Ebola syndrome.” Researchers studying macaques have a better understanding of why that might be: they’ve tracked the progression of Ebola virus through various tissues of monkeys who have survived acute infections and found evidence of long-term viral persistence and possible replication.

“[T]hey essentially found that the Ebola virus can persist in a number of sites that we consider immune privileged, including the eye, the brain, and the reproductive organs, or the testes,” Emory University opthalmologist Steven Yeh, who treated a high-profile case of eye inflammation caused by persistent Ebola virus and studies Ebola persistence, tells The Scientist. “I think it’s got implications from the standpoint of Ebola survivorship, as to why Ebola survivors in West Africa will develop long-term survivor complications, like eye disease, central nervous system manifestations, as well as the important public health issue of viral persistence in reproductive organs and the risk of sexual transmission.”

As more and more patients survive Ebola infections, the lasting complications have become more of a public health ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies